$AKYA
Akoya Biosciences, Inc.

2022 Q4 Form 10-Q Financial Statement

#000155837022016666 Filed on November 08, 2022

View on sec.gov

Income Statement

Concept 2022 Q4 2022 Q3
Revenue $21.22M $18.85M
YoY Change 31.32% 39.89%
Cost Of Revenue $9.173M $7.945M
YoY Change 54.64% 58.17%
Gross Profit $12.05M $10.91M
YoY Change 17.8% 29.03%
Gross Profit Margin 56.77% 57.86%
Selling, General & Admin $20.95M $19.92M
YoY Change 9.99% 45.15%
% of Gross Profit 173.9% 182.65%
Research & Development $6.433M $5.466M
YoY Change 15.64% 36.68%
% of Gross Profit 53.4% 50.11%
Depreciation & Amortization $1.901M $2.081M
YoY Change 38.36% 350.43%
% of Gross Profit 15.78% 19.08%
Operating Expenses $29.64M $27.56M
YoY Change 9.74% 43.6%
Operating Profit -$17.59M -$16.65M
YoY Change 4.83% 55.07%
Interest Expense -$1.070M -$1.109M
YoY Change 26.78% 45.35%
% of Operating Profit
Other Income/Expense, Net -$240.0K -$89.00K
YoY Change 44.58% -29.37%
Pretax Income -$18.90M -$17.85M
YoY Change 6.25% 53.52%
Income Tax -$26.00K $21.00K
% Of Pretax Income
Net Earnings -$18.88M -$17.87M
YoY Change 6.8% 53.84%
Net Earnings / Revenue -88.95% -94.8%
Basic Earnings Per Share -$0.47
Diluted Earnings Per Share -$0.50 -$0.47
COMMON SHARES
Basic Shares Outstanding 37.96M 37.89M
Diluted Shares Outstanding 37.90M

Balance Sheet

Concept 2022 Q4 2022 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $81.22M $81.70M
YoY Change -28.18% -32.0%
Cash & Equivalents $74.23M $51.84M
Short-Term Investments $6.989M $29.87M
Other Short-Term Assets $6.764M $8.297M
YoY Change -27.09% -15.44%
Inventory $14.49M $13.06M
Prepaid Expenses
Receivables $9.729M $8.680M
Other Receivables $0.00 $0.00
Total Short-Term Assets $112.2M $111.7M
YoY Change -20.32% -23.28%
LONG-TERM ASSETS
Property, Plant & Equipment $10.17M $10.49M
YoY Change 35.89% 61.61%
Goodwill $18.26M $18.26M
YoY Change 0.0% 0.0%
Intangibles $20.05M $20.44M
YoY Change -5.21% -4.36%
Long-Term Investments
YoY Change
Other Assets $688.0K $340.0K
YoY Change 100.0% 0.59%
Total Long-Term Assets $63.83M $64.71M
YoY Change 27.43% 30.07%
TOTAL ASSETS
Total Short-Term Assets $112.2M $111.7M
Total Long-Term Assets $63.83M $64.71M
Total Assets $176.0M $176.5M
YoY Change -7.79% -9.7%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $10.63M $8.172M
YoY Change 12.64% 100.74%
Accrued Expenses $16.52M $14.04M
YoY Change 22.44% 63.3%
Deferred Revenue $6.279M $5.876M
YoY Change 40.03% 34.96%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $620.0K $593.0K
YoY Change 127.94% 112.54%
Total Short-Term Liabilities $37.06M $31.68M
YoY Change 33.86% 83.13%
LONG-TERM LIABILITIES
Long-Term Debt $63.28M $52.71M
YoY Change 94.87% 62.88%
Other Long-Term Liabilities $16.36M $16.16M
YoY Change 78.17% 102.96%
Total Long-Term Liabilities $63.28M $52.71M
YoY Change 94.87% 62.88%
TOTAL LIABILITIES
Total Short-Term Liabilities $37.06M $31.68M
Total Long-Term Liabilities $63.28M $52.71M
Total Liabilities $117.5M $101.4M
YoY Change 68.86% 74.72%
SHAREHOLDERS EQUITY
Retained Earnings -$166.7M -$147.9M
YoY Change 73.5% 88.53%
Common Stock $2.000K $2.000K
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $58.58M $75.09M
YoY Change
Total Liabilities & Shareholders Equity $176.0M $176.5M
YoY Change -7.79% -9.7%

Cashflow Statement

Concept 2022 Q4 2022 Q3
OPERATING ACTIVITIES
Net Income -$18.88M -$17.87M
YoY Change 6.8% 53.84%
Depreciation, Depletion And Amortization $1.901M $2.081M
YoY Change 38.36% 350.43%
Cash From Operating Activities -$10.01M -$12.17M
YoY Change 70.94% -9.14%
INVESTING ACTIVITIES
Capital Expenditures $869.0K -$3.789M
YoY Change -163.66% 102.08%
Acquisitions
YoY Change
Other Investing Activities $23.00M $11.06M
YoY Change
Cash From Investing Activities $22.13M $7.266M
YoY Change -1721.32% -487.52%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 10.27M 9.860M
YoY Change 6792.62% -22509.09%
NET CHANGE
Cash From Operating Activities -10.01M -12.17M
Cash From Investing Activities 22.13M 7.266M
Cash From Financing Activities 10.27M 9.860M
Net Change In Cash 22.39M 4.955M
YoY Change -416.75% -132.36%
FREE CASH FLOW
Cash From Operating Activities -$10.01M -$12.17M
Capital Expenditures $869.0K -$3.789M
Free Cash Flow -$10.88M -$8.382M
YoY Change 142.28% -27.24%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
37900821
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
37162489
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
37660814
dei Entity File Number
EntityFileNumber
001-40344
dei Entity Registrant Name
EntityRegistrantName
Akoya Biosciences, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
47-5586242
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
23407358
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
37900821
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
37162489
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
37660814
dei Entity Address Address Line1
EntityAddressAddressLine1
100 Campus Drive
dei Amendment Flag
AmendmentFlag
false
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-09-30
dei Document Transition Report
DocumentTransitionReport
false
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
23407358
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3
0
CY2021 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3
0
CY2022Q3 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
0
CY2021Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
0
dei Entity Central Index Key
EntityCentralIndexKey
0001711933
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
CY2022Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
37947853
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
37424101
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.47
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.31
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.37
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.15
akya Standard Service Based Warranty Terms
StandardServiceBasedWarrantyTerms
P1Y
akya Extended Service Based Warranty Terms
ExtendedServiceBasedWarrantyTerms
P1Y
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
37947853
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
37424101
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.47
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.31
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.37
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.15
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
CY2022Q3 us-gaap Lease Practical Expedient Lessor Single Lease Component
LeasePracticalExpedientLessorSingleLeaseComponent
true
dei Entity Address Address Line2
EntityAddressAddressLine2
6th Floor
dei Entity Address City Or Town
EntityAddressCityOrTown
Marlborough
dei Entity Address State Or Province
EntityAddressStateOrProvince
MA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
01752
dei City Area Code
CityAreaCode
855
dei Local Phone Number
LocalPhoneNumber
896-8401
dei Security12b Title
Security12bTitle
Common Stock, par value $0.00001 per share
dei Trading Symbol
TradingSymbol
AKYA
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2021Q4 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
272000
CY2022Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
5876000
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
4484000
CY2022Q3 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
692000
dei Entity Shell Company
EntityShellCompany
false
CY2022Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
37955857
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
51836000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
113079000
CY2022Q3 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
29868000
CY2022Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
8680000
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
9444000
CY2022Q3 us-gaap Inventory Net
InventoryNet
13063000
CY2021Q4 us-gaap Inventory Net
InventoryNet
9014000
CY2022Q3 us-gaap Other Assets Current
OtherAssetsCurrent
8297000
CY2021Q4 us-gaap Other Assets Current
OtherAssetsCurrent
9277000
CY2022Q3 us-gaap Assets Current
AssetsCurrent
111744000
CY2021Q4 us-gaap Assets Current
AssetsCurrent
140814000
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
10492000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7487000
CY2022Q3 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
302000
CY2021Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
302000
CY2022Q3 akya Demo Inventory Net
DemoInventoryNet
2064000
CY2021Q4 akya Demo Inventory Net
DemoInventoryNet
2548000
CY2022Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
20442000
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
21150000
CY2022Q3 us-gaap Goodwill
Goodwill
18262000
CY2021Q4 us-gaap Goodwill
Goodwill
18262000
CY2022Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
11307000
CY2022Q3 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
1504000
CY2022Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
340000
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
344000
CY2022Q3 us-gaap Assets
Assets
176457000
CY2021Q4 us-gaap Assets
Assets
190907000
CY2022Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
8172000
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
9435000
CY2022Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
14037000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
13491000
CY2022Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
3004000
CY2022Q3 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
593000
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
31682000
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
27682000
CY2022Q3 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
1477000
CY2021Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
1330000
CY2022Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
52714000
CY2021Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
32471000
CY2022Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
125000
CY2021Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
26000
CY2021Q4 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
197000
CY2022Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
8723000
CY2022Q3 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
5956000
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-599000
CY2021Q4 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
7850000
CY2022Q3 us-gaap Liabilities
Liabilities
101369000
CY2021Q4 us-gaap Liabilities
Liabilities
69556000
CY2022Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2022Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
37947853
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
37424101
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
2000
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
2000
CY2022Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
223025000
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
217456000
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-147873000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-96107000
CY2022Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-66000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
75088000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
121351000
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
176457000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
190907000
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
18852000
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
13476000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
53640000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
38759000
CY2022Q3 us-gaap Cost Of Revenue
CostOfRevenue
7945000
CY2021Q3 us-gaap Cost Of Revenue
CostOfRevenue
5023000
us-gaap Cost Of Revenue
CostOfRevenue
22296000
us-gaap Cost Of Revenue
CostOfRevenue
14767000
CY2022Q3 us-gaap Gross Profit
GrossProfit
10907000
CY2021Q3 us-gaap Gross Profit
GrossProfit
8453000
us-gaap Gross Profit
GrossProfit
31344000
us-gaap Gross Profit
GrossProfit
23992000
CY2022Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
19922000
CY2021Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
13725000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
58705000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
31970000
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5466000
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3999000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
16778000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
10138000
CY2022Q3 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
357000
CY2021Q3 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
224000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-51766000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-26993000
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
1050000
CY2022Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1815000
CY2021Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1244000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
4975000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
3352000
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
27560000
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
19192000
us-gaap Operating Expenses
OperatingExpenses
79859000
us-gaap Operating Expenses
OperatingExpenses
46510000
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-16653000
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-10739000
us-gaap Operating Income Loss
OperatingIncomeLoss
-48515000
us-gaap Operating Income Loss
OperatingIncomeLoss
-22518000
CY2022Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-1109000
CY2021Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-763000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-2707000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-2271000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
2728000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
2476000
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-89000
CY2021Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-126000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-395000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-244000
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-17851000
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-11628000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-51617000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-25285000
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
21000
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-11000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
149000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-23000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-17872000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-11617000
us-gaap Net Income Loss
NetIncomeLoss
-51766000
us-gaap Net Income Loss
NetIncomeLoss
-25262000
us-gaap Redeemable Preferred Stock Dividends
RedeemablePreferredStockDividends
1435000
us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
296000
CY2022Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-17872000
CY2021Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-11617000
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.47
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.31
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.37
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.15
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
37900821
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
37162489
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
37660814
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
23407358
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-17872000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-11617000
us-gaap Net Income Loss
NetIncomeLoss
-51766000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
136886000
us-gaap Share Based Compensation
ShareBasedCompensation
5310000
us-gaap Share Based Compensation
ShareBasedCompensation
2628000
us-gaap Net Income Loss
NetIncomeLoss
-25262000
CY2022Q3 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
26000
us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-66000
CY2022Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
26000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-66000
CY2022Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-17846000
CY2021Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-11617000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-51832000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-25262000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
121351000
CY2022Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
55000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-16399000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1545000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
106552000
CY2022Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
164000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-17495000
CY2022Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-92000
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1721000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
90850000
CY2022Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
40000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-17872000
CY2022Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
26000
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2044000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
75088000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-51026000
CY2021Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
44000
CY2021Q1 us-gaap Dividends Preferred Stock
DividendsPreferredStock
1190000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-8082000
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
254000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-60000000
CY2021Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
99000
CY2021Q2 us-gaap Dividends Preferred Stock
DividendsPreferredStock
245000
CY2021Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
138553000
CY2021Q2 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
70542000
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt
AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt
3219000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-5563000
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1216000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
147821000
CY2021Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
30000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-11617000
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1158000
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
137392000
us-gaap Profit Loss
ProfitLoss
-51766000
us-gaap Profit Loss
ProfitLoss
-25262000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
5248000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3418000
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
381000
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
319000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-61243000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
102943000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
99000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-36000
akya Number Of Geographic Regions For Sales
NumberOfGeographicRegionsForSales
3
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-599000
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
1050000
us-gaap Investment Income Amortization Of Discount
InvestmentIncomeAmortizationOfDiscount
160000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
2728000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-82000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
2476000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-764000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
3135000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
255000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
9017000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
3976000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
2272000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1263000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1003000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1107000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
2206000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
1539000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
638000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-43489000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-30214000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
6491000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3729000
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
55000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
40774000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
11000000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-36210000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3729000
akya Proceeds From Issuance Initial Public Offering Net Of Offering Costs
ProceedsFromIssuanceInitialPublicOfferingNetOfOfferingCosts
138553000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
259000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
173000
us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
20000000
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
138000
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
250000
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
458000
us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
1207000
us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
1590000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
18456000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
113381000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
17508000
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
52138000
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
120451000
us-gaap Interest Paid Net
InterestPaidNet
2189000
us-gaap Interest Paid Net
InterestPaidNet
1942000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
352000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
438000
us-gaap Temporary Equity Accretion Of Dividends
TemporaryEquityAccretionOfDividends
1435000
akya Common Stock Issued During Period Value Conversion Of Convertible Securities
CommonStockIssuedDuringPeriodValueConversionOfConvertibleSecurities
71795000
us-gaap Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt
AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt
3219000
CY2021Q2 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
2.33
CY2022Q3 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
81704000
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-147873000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-43489000
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
18852000
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
13476000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
53640000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
38759000
us-gaap Revenue Practical Expedient Incremental Cost Of Obtaining Contract
RevenuePracticalExpedientIncrementalCostOfObtainingContract
true
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Requisite Service Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1
P4Y
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2022Q3 akya Cash Cash Equivalents And Marketable Securities Cost Basis
CashCashEquivalentsAndMarketableSecuritiesCostBasis
81770000
CY2022Q3 akya Cash Cash Equivalents And Marketable Securities Gross Unrealized Losses
CashCashEquivalentsAndMarketableSecuritiesGrossUnrealizedLosses
66000
CY2022Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
45000
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
45000
CY2022Q3 akya Cash Cash Equivalents And Marketable Securities Fair Value Disclosure
CashCashEquivalentsAndMarketableSecuritiesFairValueDisclosure
81704000
CY2022Q3 akya Number Of Marketable Debt Securities
NumberOfMarketableDebtSecurities
12
CY2022Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
16061000
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
11555000
CY2022Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
5569000
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
4068000
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
10492000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7487000
akya Demo Inventory Estimated Useful Life
DemoInventoryEstimatedUsefulLife
P3Y
CY2021 akya Demo Inventory Estimated Useful Life
DemoInventoryEstimatedUsefulLife
P3Y
CY2022Q3 akya Demo Inventory Gross
DemoInventoryGross
4179000
CY2021Q4 akya Demo Inventory Gross
DemoInventoryGross
3733000
CY2022Q3 akya Accumulated Depreciation Depletion And Amortization Demo Inventory
AccumulatedDepreciationDepletionAndAmortizationDemoInventory
2115000
CY2021Q4 akya Accumulated Depreciation Depletion And Amortization Demo Inventory
AccumulatedDepreciationDepletionAndAmortizationDemoInventory
1185000
CY2022Q3 akya Demo Inventory Net
DemoInventoryNet
2064000
CY2021Q4 akya Demo Inventory Net
DemoInventoryNet
2548000
CY2022Q3 akya Depreciation Demo Inventory
DepreciationDemoInventory
314000
akya Depreciation Demo Inventory
DepreciationDemoInventory
959000
CY2021Q3 akya Depreciation Demo Inventory
DepreciationDemoInventory
261000
akya Depreciation Demo Inventory
DepreciationDemoInventory
513000
CY2022Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
29262000
CY2022Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
8820000
CY2022Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
20442000
CY2021Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
28022000
CY2021Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
6872000
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
21150000
CY2022Q3 akya Accrued Inventory Purchases
AccruedInventoryPurchases
86000
CY2021Q4 akya Accrued Inventory Purchases
AccruedInventoryPurchases
1877000
CY2022Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
685000
CY2022Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
2772000
CY2022Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
2772000
CY2022Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
2772000
CY2022Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
2737000
CY2022Q3 akya Finite Lived Intangible Assets Amortization Expense After Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour
8704000
CY2022Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
20442000
CY2022Q3 us-gaap Goodwill
Goodwill
18262000
CY2021Q4 us-gaap Goodwill
Goodwill
18262000
CY2022Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
6359000
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
6502000
CY2022Q3 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
1295000
CY2021Q4 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
1207000
CY2022Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
6297000
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
3905000
CY2022Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
14037000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
13491000
CY2022Q3 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
462000
CY2021Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
413000
CY2022Q3 akya Debt Instrument Accretion Of Fee
DebtInstrumentAccretionOfFee
676000
CY2021Q4 akya Debt Instrument Accretion Of Fee
DebtInstrumentAccretionOfFee
384000
CY2022Q3 us-gaap Long Term Debt
LongTermDebt
52714000
CY2021Q4 us-gaap Long Term Debt
LongTermDebt
32471000
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2022Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
37947853
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
37424101
CY2022Q3 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
8174767
CY2021Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
6709218
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
21000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
149000
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-11000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-23000
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
akya Employee Retention Credit Reduction To Payroll Expense
EmployeeRetentionCreditReductionToPayrollExpense
4321000
CY2021Q3 akya Employee Retention Credit Receivables
EmployeeRetentionCreditReceivables
5093000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-17872000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-11617000
us-gaap Net Income Loss
NetIncomeLoss
-51766000
us-gaap Net Income Loss
NetIncomeLoss
-25262000
us-gaap Redeemable Preferred Stock Dividends
RedeemablePreferredStockDividends
1435000
us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
296000
CY2022Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-17872000
CY2021Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-11617000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-51766000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-26993000
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
37900821
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
37162489
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
37660814
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
23407358
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.47
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.31
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.37
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.15
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6981590
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5608329
akya Entity Number Of Business Activities
EntityNumberOfBusinessActivities
1
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
18852000
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
13476000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
53640000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
38759000
CY2022Q3 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
18000
us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
38000
CY2022Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
813000
us-gaap Operating Lease Expense
OperatingLeaseExpense
2328000
CY2022Q3 us-gaap Lease Cost
LeaseCost
1023000
us-gaap Lease Cost
LeaseCost
2858000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
803000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
3103000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
2737000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
2799000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
2599000
CY2022Q3 akya Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
2103000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
14144000
CY2022Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
2417000
CY2022Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
11727000
CY2022Q3 us-gaap Finance Lease Liability Payments Remainder Of Fiscal Year
FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear
175000
CY2022Q3 us-gaap Finance Lease Liability Payments Due Next Twelve Months
FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
623000
CY2022Q3 us-gaap Finance Lease Liability Payments Due Year Two
FinanceLeaseLiabilityPaymentsDueYearTwo
495000
CY2022Q3 us-gaap Finance Lease Liability Payments Due Year Three
FinanceLeaseLiabilityPaymentsDueYearThree
146000
CY2022Q3 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
1439000
CY2022Q3 us-gaap Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
154000
CY2022Q3 us-gaap Finance Lease Liability
FinanceLeaseLiability
1285000
CY2022Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y9M18D
CY2022Q3 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P2Y7M6D
CY2022Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0785
CY2022Q3 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.0719
us-gaap Operating Lease Payments
OperatingLeasePayments
2211000
us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
39000
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
458000

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
R44.htm Edgar Link pending
0001558370-22-016666-index-headers.html Edgar Link pending
0001558370-22-016666-index.html Edgar Link pending
0001558370-22-016666.txt Edgar Link pending
0001558370-22-016666-xbrl.zip Edgar Link pending
akya-20220930.xsd Edgar Link pending
akya-20220930x10q.htm Edgar Link pending
akya-20220930xex31d1.htm Edgar Link pending
akya-20220930xex31d2.htm Edgar Link pending
akya-20220930xex32d1.htm Edgar Link pending
akya-20220930xex32d2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
akya-20220930_pre.xml Edgar Link unprocessable
akya-20220930_cal.xml Edgar Link unprocessable
akya-20220930_lab.xml Edgar Link unprocessable
akya-20220930_def.xml Edgar Link unprocessable
akya-20220930x10q_htm.xml Edgar Link completed
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending